TTM
$99.2B
YoY change
+6.0%
5Y CAGR
+2.7%
Peak year (FY2025)
$94.2B
Cumulative revenue
$2.01T
Revenue history chart for Johnson & Johnson (JNJ) from 2016 to 2025
Latest: $94.2B
Revenue growth chart for Johnson & Johnson (JNJ) from 2016 to 2025
Latest: +6.0%
Revenue history table for Johnson & Johnson (JNJ) from 1985 to 2025
| FY2025 | $94.2B | +6.0% | +$5.37B | ||
| FY2024 | $88.8B | +4.3% | +$3.66B | ||
| FY2023 | $85.2B | +6.5% | +$5.17B | ||
| FY2022 | $80B | +1.6% | +$1.25B | ||
| FY2021 | $78.7B | -4.7% | -$3.84B | ||
| FY2020 | $82.6B | +0.6% | +$525M | ||
| FY2019 | $82.1B | +0.6% | +$478M | ||
| FY2018 | $81.6B | +6.7% | +$5.13B | ||
| FY2017 | $76.5B | +6.3% | +$4.56B | ||
| FY2016 | $71.9B | +2.6% | +$1.82B | ||
| FY2015 | $70.1B | -5.7% | -$4.26B | ||
| FY2014 | $74.3B | +4.2% | +$3.02B | ||
| FY2013 | $71.3B | +6.1% | +$4.09B | ||
| FY2012 | $67.2B | +3.4% | +$2.19B | ||
| FY2011 | $65B | +5.6% | +$3.44B | ||
| FY2010 | $61.6B | -0.5% | -$310M | ||
| FY2009 | $61.9B | -2.9% | -$1.85B | ||
| FY2008 | $63.7B | +4.3% | +$2.65B | ||
| FY2007 | $61.1B | +14.6% | +$7.77B | ||
| FY2006 | $53.3B | +5.6% | +$2.81B | ||
| FY2005 | $50.5B | +6.7% | +$3.17B | ||
| FY2004 | $47.3B | +13.1% | +$5.49B | ||
| FY2003 | $41.9B | +15.3% | +$5.56B | ||
| FY2002 | $36.3B | +12.3% | +$3.98B | ||
| FY2001 | $32.3B | +10.8% | +$3.15B | ||
| FY2000 | $29.2B | +4.2% | +$1.17B | ||
| FY1999 | $28B | +16.7% | +$4.01B | ||
| FY1998 | $24B | +6.0% | +$1.37B | ||
| FY1997 | $22.6B | +4.7% | +$1.01B | ||
| FY1996 | $21.6B | +14.7% | +$2.78B | ||
| FY1995 | $18.8B | +19.8% | +$3.11B | ||
| FY1994 | $15.7B | +11.3% | +$1.6B | ||
| FY1993 | $14.1B | +2.8% | +$385M | ||
| FY1992 | $13.8B | +10.5% | +$1.31B | ||
| FY1991 | $12.4B | +10.8% | +$1.22B | ||
| FY1990 | $11.2B | +15.1% | +$1.48B | ||
| FY1989 | $9.76B | +8.4% | +$757M | ||
| FY1988 | $9B | +12.3% | +$988M | ||
| FY1987 | $8.01B | +14.4% | +$1.01B | ||
| FY1986 | $7B | +9.1% | +$582M | ||
| FY1985 | $6.42B | — | — |
- FY2025$94.2B+6.0%
- FY2024$88.8B+4.3%
- FY2023$85.2B+6.5%
- FY2022$80B+1.6%
- FY2021$78.7B-4.7%
- FY2020$82.6B+0.6%
- FY2019$82.1B+0.6%
- FY2018$81.6B+6.7%
- FY2017$76.5B+6.3%
- FY2016$71.9B+2.6%
- FY2015$70.1B-5.7%
- FY2014$74.3B+4.2%
- FY2013$71.3B+6.1%
- FY2012$67.2B+3.4%
- FY2011$65B+5.6%
- FY2010$61.6B-0.5%
- FY2009$61.9B-2.9%
- FY2008$63.7B+4.3%
- FY2007$61.1B+14.6%
- FY2006$53.3B+5.6%
- FY2005$50.5B+6.7%
- FY2004$47.3B+13.1%
- FY2003$41.9B+15.3%
- FY2002$36.3B+12.3%
- FY2001$32.3B+10.8%
- FY2000$29.2B+4.2%
- FY1999$28B+16.7%
- FY1998$24B+6.0%
- FY1997$22.6B+4.7%
- FY1996$21.6B+14.7%
- FY1995$18.8B+19.8%
- FY1994$15.7B+11.3%
- FY1993$14.1B+2.8%
- FY1992$13.8B+10.5%
- FY1991$12.4B+10.8%
- FY1990$11.2B+15.1%
- FY1989$9.76B+8.4%
- FY1988$9B+12.3%
- FY1987$8.01B+14.4%
- FY1986$7B+9.1%
- FY1985$6.42B—
Revenue values are taken from Johnson & Johnson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current revenue (TTM) is $99.2B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Johnson & Johnson (JNJ) most recent annual revenue stands at $94.2B (2025) – grew 6.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Johnson & Johnson revenue compounded at +2.7% per year, sustaining 4 straight years of year-over-year growth.
The highest annual revenue of $94.2B was reported in 2025. The lowest in the available history was $6.42B in 1985.
Johnson & Johnson Revenue by Year
Johnson & Johnson Revenue 2025: $94.2B
In 2025, Johnson & Johnson reported revenue of $94.2B, grew 6.0% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Revenue 2024: $88.8B
Johnson & Johnson revenue in 2024 was $88.8B, edged up 4.3% from 2023.
Johnson & Johnson Revenue 2023: $85.2B
2023's revenue for Johnson & Johnson came in at $85.2B, grew 6.5% from 2022.
Johnson & Johnson Revenue 2022: $80B
Johnson & Johnson posted revenue of $80B in 2022, edged up 1.6% from 2021.
Johnson & Johnson Revenue 2021: $78.7B
Johnson & Johnson revenue in 2021 was $78.7B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Revenue
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest revenue
| $448B | |
| $65.2B | |
| $64.9B | |
| $61.2B | |
| $48.2B | |
| $44.6B | |
| $44.3B | |
| $36.7B |
- $65.2B
- $64.9B
- $61.2B
- $48.2B
- $36.7B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.28% TTM
- Dividend Profile1.97% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History7 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.